Using molecular imaging to investigate and evaluate immunotherapies - Post-doc - NS-002Desired discipline(s): Engineering - biomedical, Engineering, Biochemistry / Molecular biology, Life Sciences, Biology, Medicine, Microbiology / Immunology
Company: IMV Inc.
Project Length: 6 months to 1 year
Preferred start date: As soon as possible.
Language requirement: English
Location(s): Halifax, NS, Canada; Canada
No. of positions: 1
About the company:
This post-doctoral position is with Dr. Kim Brewer who is a part of the Biomedical Translational Imaging Centre (BIOTIC) located in Halifax, Nova Scotia.
Dr. Kim Brewer and BIOTIC are associated with both the IWK Health Centre and the Nova Scotia Health Authority. Dr. Brewer’s research group uses a number of molecular imaging technologies, including magnetic resonance imaging (MRI) and positron emission tomography (PET) to investigate immunotherapies in several preclinical cancer models. Research in the lab ranges from development of novel acquisition techniques and analysis tools for molecular imaging to studying and testing novel cancer therapeutics in preclinical models. Our current projects include study of a novel immunotherapy, investigation of immune cell recruitment in an ovarian cancer model and the development of novel imaging biomarkers for immunotherapies in glioblastoma and ovarian cancer.
Dr. Brewer is recruiting a postdoctoral fellow (PDF) to work on projects with our industry partner IMV. The PDF will be expected to work on both of these ongoing projects with other opportunities for developing original projects. This project has MITACS funding for 6 months with option to continue on solely in Dr. Brewer’s lab or continue work with IMV.
IMV Inc. was founded in 2000 and is a clinical stage biopharmaceutical company dedicated to making immunotherapy more effective, more broadly applicable, and more widely available to people facing cancer and other serious diseases (https://imv-inc.com/). IMV is pioneering a new class of immunotherapies based on the Company’s proprietary drug delivery platform, DPX™. Patented DPX technology leverages a novel mechanism of action that enables the programming of immune cells in vivo, which are aimed at generating powerful new synthetic therapeutic capabilities.
Please describe the project.:
Dr. Brewer is currently recruiting a postdoctoral fellow (PDF) to work on projects with our industry partner IMV. The PDF will be expected to work on both of these ongoing projects with other opportunities for developing original projects. This project has MITACS funding for 6 months with option to continue on solely in Dr. Brewer’s lab or continue work with IMV.
Our research is highly interdisciplinary and the lab has trainees and staff from a number of areas including microbiology and immunology, medical physics, biochemistry and biomedical engineering. All trainees are offered opportunities to develop skills across a wide range of disciplines and be exposed to both academic and industry work. The lab is physically located at the IWK and the PDF will be expected to spend time at both BIOTIC and IMV (located in Dartmouth, NS).
Dr. Brewer's webpage: https://medicine.dal.ca/departments/department-sites/radiology/contact/f...
- PhD in a biology related field (Biology, biochemistry, immunology, biomedical engineering, etc.) is preferred
- Previous experience in cell biology/biochemistry/immunology/animal models/tissue culture
- Willingness to work with preclinical models (primarily mice and rats)
- Basic immunological and histological techniques such as flow cytometry and immunofluorescent staining are beneficial
- Experience in advanced computing such as non-Windows computer environments are advantageous but not required
To apply for this position, please send the following to: email@example.com
- your CV
- Brief summary of previous work experience
- Potential start dates (your availability)
Hours: 37.5 hours/week Mon-Fri, salary range available on discussion
This is a term position with possibility of renewal